Loading…
The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model
Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then expos...
Saved in:
Published in: | Inflammation research 2020-01, Vol.69 (1), p.139-151 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3 |
---|---|
cites | cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3 |
container_end_page | 151 |
container_issue | 1 |
container_start_page | 139 |
container_title | Inflammation research |
container_volume | 69 |
creator | Sadamatsu, Hironori Takahashi, Koichiro Tashiro, Hiroki Kato, Go Noguchi, Yoshihiko Kurata, Keigo Ōmura, Satoshi Kimura, Shinya Sunazuka, Toshiaki Sueoka-Aragane, Naoko |
description | Objective
Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation.
Methods
Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting.
Results
Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages.
Conclusions
HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance. |
doi_str_mv | 10.1007/s00011-019-01302-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6942021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2332279708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhiMEoqXwAiyQJTZlERjbubKohA6FVmrFpkjsrIntnLhK7EPsUJ1n4KUZmlIuCxa-zje_PfNn2XMOrzlA_SYCAOc58JaGBJHLB9khLwTkLTRfHtIehMxlI-EgexLjNeGNaMTj7EDyRgCI4jD7fjVY5oPP0SfXuZCcZhPqOYzOWHZ62QIwTMn6BZON7Oz9JUNv2C6M--Pzt5tXufNm0dYwdPMN7pnz_YjThMkFz25cGuhmIOHbc-hX7d2AWxJzniGbwhItzcaOT7NHPY7RPrtbj7LPH06vNmf5xaeP55t3F7kuhUx5KSyvwWJXGCHKsml112pdNBYrLLk0VuuqqrqugkpWghOJRvZGyAZqiajlUXay6u6WbrJGW59mHNVudhPOexXQqb8j3g1qG76pqqXmCk4Cx3cCc_i62JjU5KK244jeUjlKSCGLmhe8JfTlP-h1WGZP5RElhajbGhqixEpRc2KcbX__GQ7qp9dq9VqR1-rWayUp6cWfZdyn_DKXALkCkUJ-a-ffb_9H9gfj47YB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332279708</pqid></control><display><type>article</type><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><source>Springer Link</source><creator>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</creator><creatorcontrib>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</creatorcontrib><description>Objective
Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation.
Methods
Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting.
Results
Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages.
Conclusions
HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</description><identifier>ISSN: 1023-3830</identifier><identifier>EISSN: 1420-908X</identifier><identifier>DOI: 10.1007/s00011-019-01302-3</identifier><identifier>PMID: 31820024</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Allergology ; Alveoli ; Antibiotics ; Asthma ; Biomedical and Life Sciences ; Biomedicine ; Bronchus ; Cytokines ; Dermatology ; Drug resistance ; Flow cytometry ; House dust ; Immunology ; Inflammation ; Interleukin 13 ; Interleukin 5 ; Interleukin 6 ; Lungs ; Macrophage inflammatory protein ; Macrophages ; Neurology ; NF-κB protein ; Original Research Paper ; Pharmacology/Toxicology ; Phosphorylation ; Polyinosinic:polycytidylic acid ; RANTES ; Respiratory tract ; Respiratory tract diseases ; Rheumatology ; Western blotting</subject><ispartof>Inflammation research, 2020-01, Vol.69 (1), p.139-151</ispartof><rights>The Author(s) 2019</rights><rights>Inflammation Research is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</citedby><cites>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</cites><orcidid>0000-0003-0461-5072</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31820024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadamatsu, Hironori</creatorcontrib><creatorcontrib>Takahashi, Koichiro</creatorcontrib><creatorcontrib>Tashiro, Hiroki</creatorcontrib><creatorcontrib>Kato, Go</creatorcontrib><creatorcontrib>Noguchi, Yoshihiko</creatorcontrib><creatorcontrib>Kurata, Keigo</creatorcontrib><creatorcontrib>Ōmura, Satoshi</creatorcontrib><creatorcontrib>Kimura, Shinya</creatorcontrib><creatorcontrib>Sunazuka, Toshiaki</creatorcontrib><creatorcontrib>Sueoka-Aragane, Naoko</creatorcontrib><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><title>Inflammation research</title><addtitle>Inflamm. Res</addtitle><addtitle>Inflamm Res</addtitle><description>Objective
Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation.
Methods
Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting.
Results
Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages.
Conclusions
HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</description><subject>Allergology</subject><subject>Alveoli</subject><subject>Antibiotics</subject><subject>Asthma</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bronchus</subject><subject>Cytokines</subject><subject>Dermatology</subject><subject>Drug resistance</subject><subject>Flow cytometry</subject><subject>House dust</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Interleukin 13</subject><subject>Interleukin 5</subject><subject>Interleukin 6</subject><subject>Lungs</subject><subject>Macrophage inflammatory protein</subject><subject>Macrophages</subject><subject>Neurology</subject><subject>NF-κB protein</subject><subject>Original Research Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Phosphorylation</subject><subject>Polyinosinic:polycytidylic acid</subject><subject>RANTES</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Rheumatology</subject><subject>Western blotting</subject><issn>1023-3830</issn><issn>1420-908X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1TAQhiMEoqXwAiyQJTZlERjbubKohA6FVmrFpkjsrIntnLhK7EPsUJ1n4KUZmlIuCxa-zje_PfNn2XMOrzlA_SYCAOc58JaGBJHLB9khLwTkLTRfHtIehMxlI-EgexLjNeGNaMTj7EDyRgCI4jD7fjVY5oPP0SfXuZCcZhPqOYzOWHZ62QIwTMn6BZON7Oz9JUNv2C6M--Pzt5tXufNm0dYwdPMN7pnz_YjThMkFz25cGuhmIOHbc-hX7d2AWxJzniGbwhItzcaOT7NHPY7RPrtbj7LPH06vNmf5xaeP55t3F7kuhUx5KSyvwWJXGCHKsml112pdNBYrLLk0VuuqqrqugkpWghOJRvZGyAZqiajlUXay6u6WbrJGW59mHNVudhPOexXQqb8j3g1qG76pqqXmCk4Cx3cCc_i62JjU5KK244jeUjlKSCGLmhe8JfTlP-h1WGZP5RElhajbGhqixEpRc2KcbX__GQ7qp9dq9VqR1-rWayUp6cWfZdyn_DKXALkCkUJ-a-ffb_9H9gfj47YB</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Sadamatsu, Hironori</creator><creator>Takahashi, Koichiro</creator><creator>Tashiro, Hiroki</creator><creator>Kato, Go</creator><creator>Noguchi, Yoshihiko</creator><creator>Kurata, Keigo</creator><creator>Ōmura, Satoshi</creator><creator>Kimura, Shinya</creator><creator>Sunazuka, Toshiaki</creator><creator>Sueoka-Aragane, Naoko</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0461-5072</orcidid></search><sort><creationdate>20200101</creationdate><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><author>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allergology</topic><topic>Alveoli</topic><topic>Antibiotics</topic><topic>Asthma</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bronchus</topic><topic>Cytokines</topic><topic>Dermatology</topic><topic>Drug resistance</topic><topic>Flow cytometry</topic><topic>House dust</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Interleukin 13</topic><topic>Interleukin 5</topic><topic>Interleukin 6</topic><topic>Lungs</topic><topic>Macrophage inflammatory protein</topic><topic>Macrophages</topic><topic>Neurology</topic><topic>NF-κB protein</topic><topic>Original Research Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Phosphorylation</topic><topic>Polyinosinic:polycytidylic acid</topic><topic>RANTES</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Rheumatology</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadamatsu, Hironori</creatorcontrib><creatorcontrib>Takahashi, Koichiro</creatorcontrib><creatorcontrib>Tashiro, Hiroki</creatorcontrib><creatorcontrib>Kato, Go</creatorcontrib><creatorcontrib>Noguchi, Yoshihiko</creatorcontrib><creatorcontrib>Kurata, Keigo</creatorcontrib><creatorcontrib>Ōmura, Satoshi</creatorcontrib><creatorcontrib>Kimura, Shinya</creatorcontrib><creatorcontrib>Sunazuka, Toshiaki</creatorcontrib><creatorcontrib>Sueoka-Aragane, Naoko</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadamatsu, Hironori</au><au>Takahashi, Koichiro</au><au>Tashiro, Hiroki</au><au>Kato, Go</au><au>Noguchi, Yoshihiko</au><au>Kurata, Keigo</au><au>Ōmura, Satoshi</au><au>Kimura, Shinya</au><au>Sunazuka, Toshiaki</au><au>Sueoka-Aragane, Naoko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</atitle><jtitle>Inflammation research</jtitle><stitle>Inflamm. Res</stitle><addtitle>Inflamm Res</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>69</volume><issue>1</issue><spage>139</spage><epage>151</epage><pages>139-151</pages><issn>1023-3830</issn><eissn>1420-908X</eissn><abstract>Objective
Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation.
Methods
Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting.
Results
Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages.
Conclusions
HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31820024</pmid><doi>10.1007/s00011-019-01302-3</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0461-5072</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1023-3830 |
ispartof | Inflammation research, 2020-01, Vol.69 (1), p.139-151 |
issn | 1023-3830 1420-908X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6942021 |
source | Springer Link |
subjects | Allergology Alveoli Antibiotics Asthma Biomedical and Life Sciences Biomedicine Bronchus Cytokines Dermatology Drug resistance Flow cytometry House dust Immunology Inflammation Interleukin 13 Interleukin 5 Interleukin 6 Lungs Macrophage inflammatory protein Macrophages Neurology NF-κB protein Original Research Paper Pharmacology/Toxicology Phosphorylation Polyinosinic:polycytidylic acid RANTES Respiratory tract Respiratory tract diseases Rheumatology Western blotting |
title | The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A27%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20non-antibiotic%20macrolide%20EM900%20attenuates%20HDM%20and%20poly(I:C)-induced%20airway%20inflammation%20with%20inhibition%20of%20macrophages%20in%20a%20mouse%20model&rft.jtitle=Inflammation%20research&rft.au=Sadamatsu,%20Hironori&rft.date=2020-01-01&rft.volume=69&rft.issue=1&rft.spage=139&rft.epage=151&rft.pages=139-151&rft.issn=1023-3830&rft.eissn=1420-908X&rft_id=info:doi/10.1007/s00011-019-01302-3&rft_dat=%3Cproquest_pubme%3E2332279708%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2332279708&rft_id=info:pmid/31820024&rfr_iscdi=true |